{"id":"https://openalex.org/W1970381908","doi":"https://doi.org/10.1016/s0021-9673(99)01117-6","title":"Direct, preparative enantioselective chromatography of propranolol hydrochloride and thioridazine hydrochloride using carbon dioxide-based mobile phases","display_name":"Direct, preparative enantioselective chromatography of propranolol hydrochloride and thioridazine hydrochloride using carbon dioxide-based mobile phases","publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W1970381908","doi":"https://doi.org/10.1016/s0021-9673(99)01117-6","mag":"1970381908","pmid":"https://pubmed.ncbi.nlm.nih.gov/10674944"},"language":"en","primary_location":{"id":"doi:10.1016/s0021-9673(99)01117-6","doi":"https://doi.org/10.1016/s0021-9673(99)01117-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0021-9673(99)01117-6","pdf_url":null,"source":{"id":"https://openalex.org/S176136234","display_name":"Journal of Chromatography A","issn_l":"0021-9673","issn":["0021-9673","1873-3778"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography A","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031471721","display_name":"Fiona Geiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286566","display_name":"Daicel Chiral Technologies (United States)","ror":"https://ror.org/02h076f86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120603","https://openalex.org/I4405286566"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Fiona Geiser","raw_affiliation_strings":["Chiral Technologies, Inc., Exton, PA 19341, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiral Technologies, Inc., Exton, PA 19341, USA","institution_ids":["https://openalex.org/I4405286566"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Martin Schultz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138659443","display_name":"Widener University","ror":"https://ror.org/00nsyd297","country_code":"US","type":"education","lineage":["https://openalex.org/I138659443"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Schultz","raw_affiliation_strings":["Widener University, Chemistry Department, Chester, PA 19013, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Widener University, Chemistry Department, Chester, PA 19013, USA","institution_ids":["https://openalex.org/I138659443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004556948","display_name":"Linda R. Betz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138659443","display_name":"Widener University","ror":"https://ror.org/00nsyd297","country_code":"US","type":"education","lineage":["https://openalex.org/I138659443"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Betz","raw_affiliation_strings":["Widener University, Chemistry Department, Chester, PA 19013, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Widener University, Chemistry Department, Chester, PA 19013, USA","institution_ids":["https://openalex.org/I138659443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071371978","display_name":"Mohamed Shaimi","orcid":"https://orcid.org/0000-0002-6664-4760","observed_orcids":["https://orcid.org/0000-0002-6664-4760"]},"institutions":[{"id":"https://openalex.org/I4405286566","display_name":"Daicel Chiral Technologies (United States)","ror":"https://ror.org/02h076f86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120603","https://openalex.org/I4405286566"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamed Shaimi","raw_affiliation_strings":["Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA","institution_ids":["https://openalex.org/I4405286566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100367858","display_name":"James Lee","orcid":"https://orcid.org/0000-0002-8372-9598","observed_orcids":["https://orcid.org/0000-0002-8372-9598"]},"institutions":[{"id":"https://openalex.org/I4405286566","display_name":"Daicel Chiral Technologies (United States)","ror":"https://ror.org/02h076f86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120603","https://openalex.org/I4405286566"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Lee","raw_affiliation_strings":["Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA","institution_ids":["https://openalex.org/I4405286566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011364887","display_name":"William L. Champion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286566","display_name":"Daicel Chiral Technologies (United States)","ror":"https://ror.org/02h076f86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120603","https://openalex.org/I4405286566"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Champion","raw_affiliation_strings":["Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiral Technologies, Inc., 730 Springdale Drive, P.O. Box 564, Exton, PA 19341, USA","institution_ids":["https://openalex.org/I4405286566"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031471721"],"corresponding_institution_ids":["https://openalex.org/I4405286566"],"apc_list":{"value":4040,"currency":"USD","value_usd":4040},"apc_paid":null,"fwci":1.2459,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.71465792,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"865","issue":"1-2","first_page":"227","last_page":"233"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13128","display_name":"Chromatography in Natural Products","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chiral-chromatography","display_name":"chiral chromatography","score":0.9290000200271606},{"id":"https://openalex.org/keywords/preparative-chromatography","display_name":"preparative chromatography","score":0.8309999704360962},{"id":"https://openalex.org/keywords/propranolol-hydrochloride","display_name":"propranolol hydrochloride","score":0.9909999966621399},{"id":"https://openalex.org/keywords/thioridazine-hydrochloride","display_name":"thioridazine hydrochloride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/carbon-dioxide-mobile-phase","display_name":"carbon dioxide mobile phase","score":0.8169999718666077},{"id":"https://openalex.org/keywords/chiralpak-ad","display_name":"Chiralpak AD","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chiral-stationary-phase","display_name":"chiral stationary phase","score":0.7889999747276306},{"id":"https://openalex.org/keywords/hydrochloride","display_name":"hydrochloride salts","score":0.6669999957084656},{"id":"https://openalex.org/keywords/methanol","display_name":"methanol","score":0.4339999854564667},{"id":"https://openalex.org/keywords/isotopic-ratios","display_name":"isotopic ratios","score":0.47600001096725464},{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9400390982627869},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7064869403839111},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.6569901704788208},{"id":"https://openalex.org/C146686406","wikidata":"https://www.wikidata.org/wiki/Q898628","display_name":"Enantioselective synthesis","level":3,"score":0.6152483820915222},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.592980146408081},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.5784046649932861},{"id":"https://openalex.org/C40325409","wikidata":"https://www.wikidata.org/wiki/Q2360668","display_name":"Mass spectrum","level":3,"score":0.464067280292511},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.4462854266166687},{"id":"https://openalex.org/C2779607525","wikidata":"https://www.wikidata.org/wiki/Q14982","display_name":"Methanol","level":2,"score":0.4415874183177948},{"id":"https://openalex.org/C2909915070","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol Hydrochloride","level":3,"score":0.43078261613845825},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.41198229789733887},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.39666348695755005},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.33076560497283936},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.28966009616851807},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.07898515462875366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.05223935842514038},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000432","descriptor_name":"Methanol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002245","descriptor_name":"Carbon Dioxide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002845","descriptor_name":"Chromatography","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0021-9673(99)01117-6","doi":"https://doi.org/10.1016/s0021-9673(99)01117-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0021-9673(99)01117-6","pdf_url":null,"source":{"id":"https://openalex.org/S176136234","display_name":"Journal of Chromatography A","issn_l":"0021-9673","issn":["0021-9673","1873-3778"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography A","raw_type":"journal-article"},{"id":"pmid:10674944","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10674944","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chromatography. A","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1486744490","https://openalex.org/W1985124305","https://openalex.org/W2009027442","https://openalex.org/W2016228987","https://openalex.org/W2017979260","https://openalex.org/W2069276755","https://openalex.org/W2141517785","https://openalex.org/W2151711536","https://openalex.org/W2316391669","https://openalex.org/W4393197712"],"related_works":["https://openalex.org/W2386970787","https://openalex.org/W2111813396","https://openalex.org/W2112643267","https://openalex.org/W2375707447","https://openalex.org/W2090986262","https://openalex.org/W2008457527","https://openalex.org/W3013330734","https://openalex.org/W2354486463","https://openalex.org/W2072418777","https://openalex.org/W2035063535"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}